Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”

Anja Tiede, Benjamin Maasoumy

Clin Mol Hepatol. 2025;31(2):e176-e179. Published online February 10, 2025

DOI: https://doi.org/10.3350/cmh.2025.0135

View: 837 Download: 20 Crossref: 1

Editorial

Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”

Georg Semmler, Lorenz Balcar, Mattias Mandorfer

Clin Mol Hepatol. 2025;31(2):615-619. Published online January 6, 2025

DOI: https://doi.org/10.3350/cmh.2024.1180

View: 923 Download: 50 Web of Science: 3 Crossref: 2

Review

Stem cell exosomes: new hope and future potential for relieving liver fibrosis

Lihua Li, Yongjie Liu, Kunpeng Wang, Jinggang Mo, Zhiyong Weng, Hao Jiang, Chong Jin

Clin Mol Hepatol. 2025;31(2):333-349. Published online November 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0854

View: 5062 Download: 352 Web of Science: 1 Crossref: 1

Original Article

Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis

Anja Tiede, Lena Stockhoff, Zhaoli Liu, Hannah Rieland, Jim B. Mauz, Valerie Ohlendorf, Birgit Bremer, Jennifer Witt, Anke Kraft, Markus Cornberg, Jan B. Hinrichs, Bernhard C. Meyer, Heiner Wedemeyer, Cheng-Jian Xu, Christine S. Falk, Benjamin Maasoumy

Clin Mol Hepatol. 2025;31(1):240-255. Published online November 21, 2024

DOI: https://doi.org/10.3350/cmh.2024.0587

View: 2190 Download: 246 Web of Science: 4 Crossref: 2

Correspondence

Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”

Do Seon Song, Dong Joon Kim

Clin Mol Hepatol. 2024;30(4):1012-1015. Published online June 18, 2024

DOI: https://doi.org/10.3350/cmh.2024.0448

View: 1597 Download: 22

Original Article

Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma

Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su

Clin Mol Hepatol. 2024;30(3):406-420. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0103

View: 4507 Download: 218 Web of Science: 11 Crossref: 11

Snapshot

Immunopathogenesis of liver fibrosis in steatotic liver disease

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 3923 Download: 127

Original Article

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding

Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021

DOI: https://doi.org/10.3350/cmh.2020.0261

View: 9286 Download: 246 Web of Science: 18 Crossref: 18

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The lymphatic system in alcohol-associated liver disease

Reiichiro Kondo, Yasuko Iwakiri

Clin Mol Hepatol. 2020;26(4):633-638. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0179

View: 10186 Download: 164 Web of Science: 3 Crossref: 3

Original Article

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals

Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti

Clin Mol Hepatol. 2018;24(2):151-162. Published online April 24, 2018

DOI: https://doi.org/10.3350/cmh.2017.0059

View: 7691 Download: 122 Web of Science: 15 Crossref: 13

Review

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 16001 Download: 349 Web of Science: 28 Crossref: 30

6

Hepatic tuberculosis presenting as a Large Liver mass

Yong Moon Shin, M.D.

Clin Mol Hepatol. 2010;16(2):197-200. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.197

View: 4630 Download: 28 Crossref: 2

1

Transient elastography, true or false?

Yeon Seok Seo

Clin Mol Hepatol. 2009;15(4):431-437. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.431

View: 4353 Download: 26 Crossref: 2

3

Changes in liver stiffness during the course of acute hepatitis A

Yeon Seok Seo, M.D., Soon Ho Um, M.D., Sang-jun Suh, M.D., Eun Suk Jung, M.D., Jin Su Jang, M.D., Yong Dae Kwon, M.D., Sang Hoon Park, M.D., Bora Keum, M.D., Yong Sik Kim, M.D., Yoon Tae Jeen, M.D., Hoon Jai Chun, M.D., Chang Duck Kim, M.D., Ho Sang Ryu, M.D.

Clin Mol Hepatol. 2008;14(4):465-473. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.465

View: 5465 Download: 27 Crossref: 11

7

The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis

Yeon Seok Seo

Clin Mol Hepatol. 2008;14(1):116-121. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.116

View: 4777 Download: 18

2

Cerulein Pancreatitis: Oxidative Stress, Inflammation, and Apoptosis

Hye Young Kim

Clin Mol Hepatol. 2008;12(2):74-80.

View: 2208 Download: 12

1 |

Viewed By 12009	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7526	MAFLD: How is it different from NAFLD?
Viewed By 6589	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5781	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5399	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search